Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE2
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure
- Status
- COMPLETED
- Phase
- PHASE4
Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
- Status
- TERMINATED
- Phase
- PHASE2
Cord Blood Expansion on Mesenchymal Stem Cells
- Status
- COMPLETED
- Phase
- PHASE1
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects
- Status
- COMPLETED
- Phase
- PHASE3
LEA29Y (Belatacept) Emory Edmonton Protocol
- Status
- COMPLETED
- Phase
- PHASE2
Strategies to Improve Islet Survival
- Status
- COMPLETED
- Phase
- PHASE2
Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors
- Status
- COMPLETED
- Phase
- PHASE4
A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- NA
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Islet Transplantation in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3